These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

255 related items for PubMed ID: 31294617

  • 1. Mycophenolate mofetil and atopic dermatitis: systematic review and meta-analysis.
    Phan K, Smith SD.
    J Dermatolog Treat; 2020 Dec; 31(8):810-814. PubMed ID: 31294617
    [Abstract] [Full Text] [Related]

  • 2. Mycophenolate Mofetil in Severe Atopic Dermatitis: A Review.
    Prussick L, Plotnikova N, Gottlieb A.
    J Drugs Dermatol; 2016 Jun 01; 15(6):715-8. PubMed ID: 27272078
    [Abstract] [Full Text] [Related]

  • 3. Mycophenolate mofetil therapy in adult patients with recalcitrant atopic dermatitis.
    Dias-Polak D, Bergman R, Avitan-Hersh E.
    J Dermatolog Treat; 2019 Feb 01; 30(1):49-51. PubMed ID: 29683760
    [Abstract] [Full Text] [Related]

  • 4. [Severe adult atopic dermatitis: treatment with mycophenolate mofetil in 8 patients].
    Ballester I, Silvestre JF, Pérez-Crespo M, Lucas A.
    Actas Dermosifiliogr; 2009 Dec 01; 100(10):883-7. PubMed ID: 20038365
    [Abstract] [Full Text] [Related]

  • 5. Mycophenolate mofetil is effective in the treatment of atopic dermatitis.
    Grundmann-Kollmann M, Podda M, Ochsendorf F, Boehncke WH, Kaufmann R, Zollner TM.
    Arch Dermatol; 2001 Jul 01; 137(7):870-3. PubMed ID: 11453805
    [Abstract] [Full Text] [Related]

  • 6. Reversible interstitial lung disease following treatment of atopic dermatitis with mycophenolate mofetil.
    Tull TJ, Toma T, Menagé HP.
    Clin Exp Dermatol; 2016 Aug 01; 41(6):702-3. PubMed ID: 27079159
    [No Abstract] [Full Text] [Related]

  • 7. Mycophenolate mofetil therapy for moderate to severe atopic dermatitis.
    Murray ML, Cohen JB.
    Clin Exp Dermatol; 2007 Jan 01; 32(1):23-7. PubMed ID: 17059445
    [Abstract] [Full Text] [Related]

  • 8. Update on systemic therapies for atopic dermatitis.
    Denby KS, Beck LA.
    Curr Opin Allergy Clin Immunol; 2012 Aug 01; 12(4):421-6. PubMed ID: 22622476
    [Abstract] [Full Text] [Related]

  • 9. Treatment of atopic eczema with oral mycophenolate mofetil.
    Neuber K, Schwartz I, Itschert G, Dieck AT.
    Br J Dermatol; 2000 Aug 01; 143(2):385-91. PubMed ID: 10951150
    [Abstract] [Full Text] [Related]

  • 10. Prescribing practices for systemic agents in the treatment of severe pediatric atopic dermatitis in the US and Canada: The PeDRA TREAT survey.
    Totri CR, Eichenfield LF, Logan K, Proudfoot L, Schmitt J, Lara-Corrales I, Sugarman J, Tom W, Siegfried E, Cordoro K, Paller AS, Flohr C.
    J Am Acad Dermatol; 2017 Feb 01; 76(2):281-285. PubMed ID: 27855965
    [Abstract] [Full Text] [Related]

  • 11. Systemic mycophenolate mofetil in comparison with systemic cyclosporin A in high-risk keratoplasty patients: 3 years' results of a randomized prospective clinical trial.
    Reinhard T, Reis A, Böhringer D, Malinowski M, Voiculescu A, Heering P, Godehardt E, Sunmacher R.
    Graefes Arch Clin Exp Ophthalmol; 2001 Jun 01; 239(5):367-72. PubMed ID: 11482341
    [Abstract] [Full Text] [Related]

  • 12. Mycophenolate mofetil: a dermatologic perspective.
    Mydlarski PR.
    Skin Therapy Lett; 2005 Apr 01; 10(3):1-6. PubMed ID: 15986076
    [Abstract] [Full Text] [Related]

  • 13. Candida Esophagitis Associated With Mycophenolate Mofetil Treatment of Atopic Dermatitis.
    Kurayev A, Gottlieb AB.
    J Drugs Dermatol; 2016 Oct 01; 15(10):1267-1269. PubMed ID: 27741346
    [Abstract] [Full Text] [Related]

  • 14. Usage and effectiveness of systemic treatments in adults with severe atopic eczema: First results of the German Atopic Eczema Registry TREATgermany.
    Schmitt J, Abraham S, Trautmann F, Stephan V, Fölster-Holst R, Homey B, Bieber T, Novak N, Sticherling M, Augustin M, Kleinheinz A, Elsner P, Weidinger S, Werfel T.
    J Dtsch Dermatol Ges; 2017 Jan 01; 15(1):49-59. PubMed ID: 27862987
    [Abstract] [Full Text] [Related]

  • 15. Mycophenolate mofetil. A useful immunosuppressive in inflammatory eye disease.
    Larkin G, Lightman S.
    Ophthalmology; 1999 Feb 01; 106(2):370-4. PubMed ID: 9951492
    [Abstract] [Full Text] [Related]

  • 16. Mycophenolate mofetil for severe childhood atopic dermatitis: experience in 14 patients.
    Heller M, Shin HT, Orlow SJ, Schaffer JV.
    Br J Dermatol; 2007 Jul 01; 157(1):127-32. PubMed ID: 17489974
    [Abstract] [Full Text] [Related]

  • 17. Effect of mycophenolate mofetil therapy on inosine monophosphate dehydrogenase induction in red blood cells of heart transplant recipients.
    Weigel G, Griesmacher A, Zuckermann AO, Laufer G, Mueller MM.
    Clin Pharmacol Ther; 2001 Mar 01; 69(3):137-44. PubMed ID: 11240978
    [Abstract] [Full Text] [Related]

  • 18. Systemic treatment for severe atopic dermatitis in children: a case series.
    Cheirif-Wolosky O, Elizalde-Jiménez IG, Romero MTG.
    Bol Med Hosp Infant Mex; 2022 Mar 01; 79(5):310-317. PubMed ID: 36264887
    [Abstract] [Full Text] [Related]

  • 19. Spotlight on: clinical development of mycophenolate mofetil in multiple sclerosis.
    Davies SL, Moral MA.
    Drug News Perspect; 2006 Dec 01; 19(10):632-3. PubMed ID: 17299605
    [Abstract] [Full Text] [Related]

  • 20. Defining the role of mycophenolate mofetil in the treatment of proliferative lupus nephritis.
    Lenz O, Fornoni A, Contreras G.
    Drugs; 2005 Dec 01; 65(17):2429-36. PubMed ID: 16296869
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.